<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-73881</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Echocardiographic findings and NT-proBNP level in type-2 diabetic patients with and without ischemic heart disease</dc:title>
<dc:description xml:lang="en">The aim of this study was to determine whether there are differences in echocardiographic findings or in the level of a biochemical marker (i.e. N-terminal probrain natriuretic peptide [NT-proBNP]) between controls and type-2 diabetic patients with or without ischemic heart disease. Echocardiography was used to assess left ventricular function and morphology. In addition, the plasma NT-proBNP concentration was measured. The prevalence of diastolic dysfunction was greater in diabetics without ischemic heart disease than in controls (88% vs. 74%, respectively; P &lt; .001) and the NT-proBNP concentration was higher (350.6±197.8 vs. 281.7±190.4 fmol/mL; P &lt; .001). Diabetics with ischemic heart disease had a higher NT-proBNP concentration than those without (720.4±278.1 vs. 350.6±197.8 fmol/mL, respectively; P &lt; .001). An NT-proBNP concentration &gt;490 fmol/mL had a sensitivity of 84% and a specificity of 75% for detecting ischemic heart disease in diabetics (AU)</dc:description>
<dc:creator>Coma-Canella, Isabel</dc:creator>
<dc:creator>Barba Cosials, Joaquín</dc:creator>
<dc:creator>Castaño Rodríguez, Sara</dc:creator>
<dc:creator>López Salazar, Begoña</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El objetivo de este trabajo es analizar posibles diferencias ecocardiográficas y bioquímicas (NT-proBNP) entre controles y pacientes diabéticos tipo 2 sin cardiopatía isquémica y con ella. El estudio ecocardiográfico comprendió la forma y la función ventricular izquierda. Además se determinaron las concentraciones plasmáticas de NT-proBNP. Los diabéticos sin cardiopatía isquémica presentaron mayor prevalencia de disfunción diastólica (el 88 frente al 74%; p &lt; 0,001) y mayor concentración de NT-proBNP (350,6 ± 197,8 frente a 281,7 ± 190,4 fmol/ ml; p &lt; 0,001) que los controles. Los diabéticos con cardiopatía isquémica mostraron concentraciones de NT-proBNP muy superiores a las de los diabéticos sin cardiopatía isquémica (720,4 ± 278,1 frente a 350,6 ± 197,8 fmol/ml respectivamente; p &lt; 0,001). Una concentración de NT-proBNP &gt; 490 fmol/ml tuvo el 84% de sensibilidad y el 75% de especificidad para detectar cardiopatía isquémica en pacientes diabéticos (AU)</dc:description>
<dc:source>Rev Esp Cardiol;62(10): 1184-1188, oct. 2009. tab, ilus</dc:source>
<dc:identifier>ibc-73881</dc:identifier>
<dc:title xml:lang="es">Estudio ecocardiográfico y de la concentración de NT-proBNP en pacientes diabéticos tipo 2 con y sin cardiopatía isquémica</dc:title>
<dc:subject>^d3946^s22012</dc:subject>
<dc:subject>^d30650^s22016</dc:subject>
<dc:subject>^d23233^s22074</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:type>article</dc:type>
<dc:date>200910</dc:date>
</metadata>
</record>
</ibecs-document>
